To celebrate our 10-year milestone of advancing genetic insights and transforming patient care, test your knowledge with Baylor Genetics trivia all month long! What is the fastest turnaround time offered by Baylor Genetics for Rapid Whole Genome Sequencing (rWGS)?

In a retrospective analysis of 274 epilepsy patients at Baylor Genetics, 35.4% were diagnosed definitively through WGS. 15% found crucial genetic changes missed by panels. Rapid WGS is crucial for acutely ill patients, providing timely insights.

To celebrate Baylor Genetics' 10-year milestone of advancing genetic insights & transforming patient care, let's start off with some trivia to discover a few fun facts about the journey. How many clinical genetic tests has Baylor Genetics performed since its founding?

Dr. Christine Eng, our CMO & CQO, will deliver a showcase talk at #PMWC25 on February 5! "RNA Sequencing to Help Identify Rare Genetic Disorders," will delve into the transformative role of RNA sequencing in advancing rare disease diagnosis & patient care.

At Baylor Genetics, we celebrate #BlackHistoryMonth by recognizing the invaluable contributions Black scientists, healthcare providers, and leaders have made—and continue to make—to the field of genetics and healthcare innovation. #ThinkBG #Genetics

Join Baylor Genetics as a Quality Assurance Specialist (IVD) and help drive excellence in genetic testing. Based in Houston, TX, this hybrid role focuses on quality assurance across all stages of diagnostics.​ Apply today: #Hiring #Genetics

Baylor Genetics & Illumina recently co-hosted a virtual event diving into the future of healthcare!​ Experts shared groundbreaking insights into the diagnostic, clinical, & economic power of WGS for neurological conditions.​ Watch the replay: #Genetics

Shannon Kieran, VP of Product at Baylor Genetics, dives into how our integration with Epic Aura is making an impact.​ By streamlining genetic testing into healthcare workflows, we’re improving efficiency, empowering providers, and creating better outcomes for patients. #ThinkBG

Whole Exome Sequencing (WES) can help identify genetic causes often missed by standard tests, enabling earlier, more accurate diagnoses & guiding better management of complex conditions. ​ Learn how WES can empower your diagnosis & improve patient care:

Our Whole Exome (WES) & Whole Genome Sequencing (WGS) include RNAseq to help classify variants linked to epilepsy. This powerful combination streamlines medical management and helps optimize seizure treatment for your patients. ​ Learn more: ​ #ThinkBG

At Baylor Genetics, we’re dedicated to empowering patients with the genetic insights they need to make confident, informed decisions about their health. ​ Visit ​to learn more. #ThinkBG #Genetics

We strive to honor MLK Jr’s legacy by advancing equitable access to genetic testing and working toward a future where every patient has the opportunity to receive life-changing answers. His words resonate with our mission. ​ #MLKDay

Baylor Genetics is hiring a Facility Maintenance Manager! Responsibilities include handling repairs, facility improvement projects, & ensuring a safe, efficient environment for cutting-edge genetic testing. Join us & make a real impact in healthcare.

As we raise awareness for National Birth Defects Awareness Month, let's explore the role genetics plays in birth defects. Approximately what percentage of birth defects are linked to genetic factors?

Curious about the role of #RNAseq in resolving variants of uncertain significance? Check out our webinar on how RNAseq is enhancing rare disease insights from Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS). #ThinkBG #Genome #Exome

Baylor Genetics conducted a retrospective analysis of Whole Genome Sequencing (WGS) results from over 1,100 patients and found that WGS provided a molecular diagnosis for up to 74% of individuals with developmental delays and intellectual disabilities.

Baylor Genetics is now live on Epic Aura, offering faster access to genetic test results! We are proud to be the first lab to offer WGS through Aura, empowering neonatal & pediatric ICUs with timely, life-saving insights.

Dr. Christine Eng, CMO and CQO at Baylor Genetics, will take the stage at #PMWC25 on Feb 5! ​ Her talk will highlight how #RNAseq is transforming rare disease diagnosis & patient care by uncovering genetic variants previously undetectable. ​ @PMWCintl

Ugly Sweater contest, Baylor Genetics-style! A huge thank you to everyone who participated and made this celebration one to remember.​ #ThinkBG #UglySweaterContest

Kengo Takishima, our President & CEO, shares his 2025 predictions with @ChiefHealthExec, highlighting #AI's transformative role in advancing genetic testing.​ Read more: